Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol

[1]  D. Blaise,et al.  The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation , 2018, Bone Marrow Transplantation.

[2]  P. Loiseau,et al.  Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation , 2016, Front. Immunol..

[3]  S. Ciurea,et al.  Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation , 2016, Advances in hematology.

[4]  P. Thall,et al.  Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  Andrea A Zachary,et al.  Desensitization for solid organ and hematopoietic stem cell transplantation , 2014, Immunological reviews.

[6]  A. Zachary,et al.  Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  H. Tamaki,et al.  Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT , 2012, Bone Marrow Transplantation.

[8]  J. Ritz,et al.  Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. , 2011, Blood.

[9]  P. Thall,et al.  Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. , 2011, Blood.

[10]  O. Ringdén,et al.  Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation. , 2011, Transplant immunology.

[11]  A. Zachary,et al.  Barriers to successful transplantation of the sensitized patient , 2010, Expert review of clinical immunology.

[12]  J. Klein,et al.  The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. , 2007, Blood.

[13]  P. Thall,et al.  High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation , 2009, Transplantation.

[14]  E. Shpall,et al.  High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem Cell Transplantation , 2009 .

[15]  E. Hod,et al.  Platelet Transfusion Refractoriness , 2024, Plasmatology.

[16]  H. Tanaka,et al.  Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion , 2005, Bone Marrow Transplantation.

[17]  John J Spinelli,et al.  Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. , 2004, Blood.

[18]  K. Sullivan,et al.  Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. , 1989, The New England journal of medicine.

[19]  L. Sandu.  CORTICOSTEROIDS IN LANDRY-GUILLAIN-BARRÉ-STROHL SYNDROME , 1974 .

[20]  O. Fjeldborg,et al.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. , 1966, Lancet.